Interferon beta in multiple sclerosis

Saved in:
Bibliographic Details
Published in:BMJ 1997-02, Vol.314 (7080), p.600-602
Main Authors: Price, C., Napier, J. C., Holmes, J., Winyard, Graham, Cardy, Peter, Peltola, Jukka, Keranen, Tapani
Format: Article
Language:English
Subjects:
Clinical trials
Disabilities
Disease progression
Economic benefits
Experimentation
Interferons
Letters
Multiple sclerosis
Neurology
Relapse
Relapsing remitting multiple sclerosis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b328a-1a46ab1475c3d1f33f3d8bc58c0fce02974847aff9989cb396636df930ad80033
cites
container_end_page 602
container_issue 7080
container_start_page 600
container_title BMJ
container_volume 314
creator Price, C.
Napier, J. C.
Holmes, J.
Winyard, Graham
Cardy, Peter
Peltola, Jukka
Keranen, Tapani
description
doi_str_mv 10.1136/bmj.314.7080.600a
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_journals_1777530904</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>25173861</jstor_id><sourcerecordid>25173861</sourcerecordid><originalsourceid>FETCH-LOGICAL-b328a-1a46ab1475c3d1f33f3d8bc58c0fce02974847aff9989cb396636df930ad80033</originalsourceid><addsrcrecordid>eNqFkM9LwzAYhoMoOOb-AA9CQbzZ-aVfmx9HGc5NhiLo8BbSNoHWrp1JB_rfm1LZ1VMO7_N-b3gIuaQwpxTZXb6r50jTOQcBcwagT8iEpkzEmUA8JROQmYwFRXFOZt7XAJAgF5JlE3KzbnvjrHFdG-Wm11HVRrtD01f7xkS-aELgK39BzqxuvJn9vVPyvnx4W6zizcvjenG_iXNMhI6pTpnOacqzAktqES2WIi8yUYAtDCSSpyLl2lophSxylIwhK61E0KUAQJyS6_Hu3nVfB-N7VXcH14ZJRTnnGYKENFB0pIrwOe-MVXtX7bT7URTUIEQFISoIUYMQNQgJnauxU_u-c8dCklGOgtGQx2Ne-d58H3PtPhXjyDP1vF0oXK7kNv14Uq-Bvx35Yer_-V9cZXil</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777530904</pqid></control><display><type>article</type><title>Interferon beta in multiple sclerosis</title><source>BMJ Publishing</source><source>JSTOR Archival Journals</source><creator>Price, C. ; Napier, J. C. ; Holmes, J. ; Winyard, Graham ; Cardy, Peter ; Peltola, Jukka ; Keranen, Tapani</creator><creatorcontrib>Price, C. ; Napier, J. C. ; Holmes, J. ; Winyard, Graham ; Cardy, Peter ; Peltola, Jukka ; Keranen, Tapani</creatorcontrib><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.314.7080.600a</identifier><language>eng</language><publisher>London: British Medical Journal Publishing Group</publisher><subject>Clinical trials ; Disabilities ; Disease progression ; Economic benefits ; Experimentation ; Interferons ; Letters ; Multiple sclerosis ; Neurology ; Relapse ; Relapsing remitting multiple sclerosis</subject><ispartof>BMJ, 1997-02, Vol.314 (7080), p.600-602</ispartof><rights>1997 BMJ Publishing Group Ltd.</rights><rights>Copyright 1997 British Medical Journal</rights><rights>Copyright: 1997 (c) 1997 BMJ Publishing Group Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b328a-1a46ab1475c3d1f33f3d8bc58c0fce02974847aff9989cb396636df930ad80033</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/314/7080/600.2.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/314/7080/600.2.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>112,113,314,780,784,3194,27924,27925,58238,58471,77594,77595</link.rule.ids></links><search><creatorcontrib>Price, C.</creatorcontrib><creatorcontrib>Napier, J. C.</creatorcontrib><creatorcontrib>Holmes, J.</creatorcontrib><creatorcontrib>Winyard, Graham</creatorcontrib><creatorcontrib>Cardy, Peter</creatorcontrib><creatorcontrib>Peltola, Jukka</creatorcontrib><creatorcontrib>Keranen, Tapani</creatorcontrib><title>Interferon beta in multiple sclerosis</title><title>BMJ</title><addtitle>BMJ</addtitle><subject>Clinical trials</subject><subject>Disabilities</subject><subject>Disease progression</subject><subject>Economic benefits</subject><subject>Experimentation</subject><subject>Interferons</subject><subject>Letters</subject><subject>Multiple sclerosis</subject><subject>Neurology</subject><subject>Relapse</subject><subject>Relapsing remitting multiple sclerosis</subject><issn>0959-8138</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkM9LwzAYhoMoOOb-AA9CQbzZ-aVfmx9HGc5NhiLo8BbSNoHWrp1JB_rfm1LZ1VMO7_N-b3gIuaQwpxTZXb6r50jTOQcBcwagT8iEpkzEmUA8JROQmYwFRXFOZt7XAJAgF5JlE3KzbnvjrHFdG-Wm11HVRrtD01f7xkS-aELgK39BzqxuvJn9vVPyvnx4W6zizcvjenG_iXNMhI6pTpnOacqzAktqES2WIi8yUYAtDCSSpyLl2lophSxylIwhK61E0KUAQJyS6_Hu3nVfB-N7VXcH14ZJRTnnGYKENFB0pIrwOe-MVXtX7bT7URTUIEQFISoIUYMQNQgJnauxU_u-c8dCklGOgtGQx2Ne-d58H3PtPhXjyDP1vF0oXK7kNv14Uq-Bvx35Yer_-V9cZXil</recordid><startdate>19970222</startdate><enddate>19970222</enddate><creator>Price, C.</creator><creator>Napier, J. C.</creator><creator>Holmes, J.</creator><creator>Winyard, Graham</creator><creator>Cardy, Peter</creator><creator>Peltola, Jukka</creator><creator>Keranen, Tapani</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>19970222</creationdate><title>Interferon beta in multiple sclerosis</title><author>Price, C. ; Napier, J. C. ; Holmes, J. ; Winyard, Graham ; Cardy, Peter ; Peltola, Jukka ; Keranen, Tapani</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b328a-1a46ab1475c3d1f33f3d8bc58c0fce02974847aff9989cb396636df930ad80033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Clinical trials</topic><topic>Disabilities</topic><topic>Disease progression</topic><topic>Economic benefits</topic><topic>Experimentation</topic><topic>Interferons</topic><topic>Letters</topic><topic>Multiple sclerosis</topic><topic>Neurology</topic><topic>Relapse</topic><topic>Relapsing remitting multiple sclerosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Price, C.</creatorcontrib><creatorcontrib>Napier, J. C.</creatorcontrib><creatorcontrib>Holmes, J.</creatorcontrib><creatorcontrib>Winyard, Graham</creatorcontrib><creatorcontrib>Cardy, Peter</creatorcontrib><creatorcontrib>Peltola, Jukka</creatorcontrib><creatorcontrib>Keranen, Tapani</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest_Research Library</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Price, C.</au><au>Napier, J. C.</au><au>Holmes, J.</au><au>Winyard, Graham</au><au>Cardy, Peter</au><au>Peltola, Jukka</au><au>Keranen, Tapani</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interferon beta in multiple sclerosis</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>1997-02-22</date><risdate>1997</risdate><volume>314</volume><issue>7080</issue><spage>600</spage><epage>602</epage><pages>600-602</pages><issn>0959-8138</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><cop>London</cop><pub>British Medical Journal Publishing Group</pub><doi>10.1136/bmj.314.7080.600a</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-8138
ispartof BMJ, 1997-02, Vol.314 (7080), p.600-602
issn 0959-8138
1468-5833
1756-1833
language eng
recordid cdi_proquest_journals_1777530904
source BMJ Publishing; JSTOR Archival Journals
subjects Clinical trials
Disabilities
Disease progression
Economic benefits
Experimentation
Interferons
Letters
Multiple sclerosis
Neurology
Relapse
Relapsing remitting multiple sclerosis
title Interferon beta in multiple sclerosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A49%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interferon%20beta%20in%20multiple%20sclerosis&rft.jtitle=BMJ&rft.au=Price,%20C.&rft.date=1997-02-22&rft.volume=314&rft.issue=7080&rft.spage=600&rft.epage=602&rft.pages=600-602&rft.issn=0959-8138&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.314.7080.600a&rft_dat=%3Cjstor_proqu%3E25173861%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b328a-1a46ab1475c3d1f33f3d8bc58c0fce02974847aff9989cb396636df930ad80033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1777530904&rft_id=info:pmid/&rft_jstor_id=25173861&rfr_iscdi=true